124 related articles for article (PubMed ID: 1579199)
1. Heterotransplantation of a human oligoastrocytoma into nude mice: difference in tumour growth between males and females.
Verzat C; Courriere P; Hollande E
Neuropathol Appl Neurobiol; 1992 Feb; 18(1):37-51. PubMed ID: 1579199
[TBL] [Abstract][Full Text] [Related]
2. Glial fibrillary acidic protein (GFAP) in oligodendroglial tumors: gliofibrillary oligodendroglioma and transitional oligoastrocytoma as subtypes of oligodendroglioma.
Herpers MJ; Budka H
Acta Neuropathol; 1984; 64(4):265-72. PubMed ID: 6391068
[TBL] [Abstract][Full Text] [Related]
3. Phenotypic characteristics of GFAP-immunopositive oligodendroglial tumours Part I: immunohistochemical study.
Matyja E; Taraszewska A; Zabek M
Folia Neuropathol; 2001; 39(1):19-26. PubMed ID: 11678347
[TBL] [Abstract][Full Text] [Related]
4. Influence of host sex on the growth of a human glioblastoma line in athymic mice.
Verzat C; Delisle MB; Courriere P; Hollande E
Neuropathol Appl Neurobiol; 1990 Apr; 16(2):141-51. PubMed ID: 2161085
[TBL] [Abstract][Full Text] [Related]
5. Correlation of glial fibrillary acidic protein (GFAP) with grading of the neuroglial tumours.
Reyaz N; Tayyab M; Khan SA; Siddique T
J Coll Physicians Surg Pak; 2005 Aug; 15(8):472-5. PubMed ID: 16202357
[TBL] [Abstract][Full Text] [Related]
6. Phenotypic characteristics of GFAP-positive oligodendroglial tumours. Part II: ultrastructural study.
Matyja E; Taraszewska A; Nagańska E; Zabek M
Folia Neuropathol; 2001; 39(2):103-10. PubMed ID: 11680631
[TBL] [Abstract][Full Text] [Related]
7. Astrocytic characteristics of oligodendroglioma. Fine structural and immunohistochemical studies of two cases.
Kamitani H; Masuzawa H; Sato J; Kanazawa I
J Neurol Sci; 1987 May; 78(3):349-55. PubMed ID: 3585407
[TBL] [Abstract][Full Text] [Related]
8. TPPP/p25 in brain tumours: expression in non-neoplastic oligodendrocytes but not in oligodendroglioma cells.
Preusser M; Lehotzky A; Budka H; Ovádi J; Kovács GG
Acta Neuropathol; 2007 Feb; 113(2):213-5. PubMed ID: 17136548
[No Abstract] [Full Text] [Related]
9. Immunohistochemical studies on cellular character of microtumors induced by ethylnitrosourea in the rat brain utilizing anti-Leu 7 and anti-glial fibrillary acidic protein antibodies.
Yoshino T; Motoi M; Ogawa K
Acta Neuropathol; 1985; 66(2):167-9. PubMed ID: 2990142
[TBL] [Abstract][Full Text] [Related]
10. Characterization of refractile eosinophilic granular cells in oligodendroglial tumors.
Yoshida T; Nakazato Y
Acta Neuropathol; 2001 Jul; 102(1):11-9. PubMed ID: 11547945
[TBL] [Abstract][Full Text] [Related]
11. Use of monoclonal antibodies to glial fibrillary acidic protein in the cytologic diagnosis of brain tumors.
Chen Y; Zhang YX
Acta Cytol; 1989; 33(6):922-8. PubMed ID: 2588925
[TBL] [Abstract][Full Text] [Related]
12. OLIG2 is a useful immunohistochemical marker in differential diagnosis of clear cell primary CNS neoplasms.
Preusser M; Budka H; Rössler K; Hainfellner JA
Histopathology; 2007 Feb; 50(3):365-70. PubMed ID: 17257132
[TBL] [Abstract][Full Text] [Related]
13. Assessment of 1p/19q status by fluorescence in situ hybridization assay: A comparative study in oligodendroglial, mixed oligoastrocytic and astrocytic tumors.
Shukla B; Agarwal S; Suri V; Pathak P; Sharma MC; Gupta D; Sharma BS; Suri A; Halder A; Sarkar C
Neurol India; 2009; 57(5):559-66. PubMed ID: 19934553
[TBL] [Abstract][Full Text] [Related]
14. CD44 expression in primary and recurrent oligodendrogliomas and in adjacent gliotic brain tissue.
Hagel C; Stavrou DK
Neuropathol Appl Neurobiol; 1999 Aug; 25(4):313-8. PubMed ID: 10476048
[TBL] [Abstract][Full Text] [Related]
15. Ultrastructural characterization of transitional cells in oligodendrogliomas.
Kros JM; de Jong AA; van der Kwast TH
J Neuropathol Exp Neurol; 1992 Mar; 51(2):186-93. PubMed ID: 1538242
[TBL] [Abstract][Full Text] [Related]
16. Prognostic implications of glial fibrillary acidic protein containing cell types in oligodendrogliomas.
Kros JM; Van Eden CG; Stefanko SZ; Waayer-Van Batenburg M; van der Kwast TH
Cancer; 1990 Sep; 66(6):1204-12. PubMed ID: 2205356
[TBL] [Abstract][Full Text] [Related]
17. Plastic phenotype of human oligodendroglial tumour cells in vitro.
Tenenbaum L; Teugels E; Dogusan Z; Avellana-Adalid V; Hooghe-Peters EL
Neuropathol Appl Neurobiol; 1996 Aug; 22(4):302-10. PubMed ID: 8875464
[TBL] [Abstract][Full Text] [Related]
18. [Clinicopathological study of oligodendroglioma with special reference to immunohistochemical investigation].
Kubo O; Tajika Y; Toyama T; Tajika T; Sakairi M; Katahira M; Kitamura K
No Shinkei Geka; 1988 Aug; 16(9):1029-35. PubMed ID: 2462693
[TBL] [Abstract][Full Text] [Related]
19. Cerebral ganglioglioma with anaplastic oligodendroglial component.
Allegranza A; Pileri S; Frank G; Ferracini R
Histopathology; 1990 Nov; 17(5):439-41. PubMed ID: 1706300
[TBL] [Abstract][Full Text] [Related]
20. Oligodendrogliomas result from the expression of an activated mutant epidermal growth factor receptor in a RAS transgenic mouse astrocytoma model.
Ding H; Shannon P; Lau N; Wu X; Roncari L; Baldwin RL; Takebayashi H; Nagy A; Gutmann DH; Guha A
Cancer Res; 2003 Mar; 63(5):1106-13. PubMed ID: 12615729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
